Most of the world still views hydrogen-powered flight as a futuristic someday concept, but a modified Robinson R44 helicopter recently proved that the future is already hovering over Canadian soil. Unither Bioélectronique (UB) successfully completed the world’s first piloted hydrogen-electric helicopter circuit flight at Roland-Désourdy Airport in Bromont, Québec.

On April 10, 2026, UB test pilot Ric Webb took the controls to conduct the flight. It was a full-scale demonstration of takeoff, climb, pattern flight, and landing. The flight was powered by a Proton Exchange Membrane (PEM) fuel-cell-battery architecture and zero-emission green hydrogen.

The Canadian Advanced Air Mobility (CAAM) has hailed this progress as a transformative turning point for the nation’s aerospace sector. “Hydrogen flight is no longer a distant concept sitting on a roadmap. It is flying, completing circuits, being tested, being learned from, and being built into a pathway for healthcare, emergency response, and regional logistics,” said JR Hammond, Executive Director of CAAM.

“CAAM’s role is to help ensure that the ecosystem around this technology — regulation, infrastructure, investment, and public trust — moves with the same urgency,” Hammond added. 

Objective beyond aviation

Reportedly, the aircraft’s original Lycoming IO-540 engine was replaced with a high-tech propulsion suite comprising twin low-temperature PEM fuel cells, a MagniX electric motor, and a lithium-ion booster battery. To support this new system, engineers mounted a cylindrical hydrogen tank beneath the tail boom and installed specialized cooling nacelles on both sides of the helicopter’s exterior.

Operating under an experimental permit, the mission successfully transitioned the hydrogen-electric Robinson R44 from basic hovering to a complete airport traffic circuit.  Notably, the test validated the aircraft‘s PEM fuel-cell-battery architecture using locally sourced green hydrogen by executing a full profile of takeoff, climb, pattern flight, and landing.

Building on several 2025 world firsts, this latest test further validates the PEM technology’s ability to meet the high-power demands of Vertical Take-Off and Landing (VTOL) flight.  This achievement is more than just a technical win; it is the life-saving intent behind it.

Unither Bioélectronique, a subsidiary of United Therapeutics, is developing this technology to address a pressing logistics challenge: the delivery of manufactured organ alternatives. Currently, organ transport is a race against the clock. 

Using a scalable, zero-emission VTOL network, UB aims to move organs from lab to bedside without the carbon footprint — or the traffic delays — of standard transport. “This milestone shows that piloted hydrogen-electric vertical flight can move from theory to repeatable, safe, real-world testing,” said Mikaël Cardinal, Vice President, Program Management & Business Development, Organ Delivery Systems for Unither Bioélectronique.

“For Unither, the goal is clear: build the aircraft and aerial logistics systems needed to help deliver manufactured organ alternatives to patients in need, while creating a scalable zero-emission transportation network,” Cardinal added. 

Scaling technology

The mission is a cornerstone of Project Proticity, a 2024 partnership between Unither Bioélectronique and Californian chopper maker Robinson Helicopter Company designed to modernize the R44 and R66 platforms.  The collaboration aims to fast-track zero-emission helicopters toward official certification with Transport Canada Civil Aviation and the U.S. Federal Aviation Administration.

Moreover, the data gathered from this circuit flight is now being used to scale the hydrogen-electric architecture for the larger, more powerful Robinson R66 platform. 

This move toward liquid hydrogen systems will eventually unlock the payload and range necessary for long-distance medical missions and emergency response. These advancements are essential for supporting critical healthcare, emergency, and regional logistics missions.